Macquarie Group
MYOK

Macquarie Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Macquarie Group’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-475,608
Closed -$64.8M – 2401
2020
Q3 		$64.8M Buy
475,608
+457,571
+2,537% +$48.6M 0.11% 201
2020
Q2 		$1.74M Buy
18,037
+16,553
+1,115% +$1.38M ﹤0.01% 1050
2020
Q1 		$70K Buy
+1,484
New +$95.1K ﹤0.01% 1744

Macquarie Group's MYOK Position: Q4 2020 in Review

Macquarie Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 475,608 shares — an estimated $64.8M sold.

Macquarie Group first reported a position in MYOK in Q1 2020 and held it in 3 quarters. The position peaked at $64.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Macquarie Group reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Macquarie Group sold 475,608 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $64.8M.
  • Macquarie Group first reported a position in MyoKardia, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
  • Macquarie Group's MyoKardia, Inc. Common Stock position peaked at $64.8M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Macquarie Group's 13F filing for Q4 2020, filed 16 Feb 2021.